nodes	percent_of_prediction	percent_of_DWPC	metapath
Vecuronium—ABCB1—Mitomycin—urinary bladder cancer	0.39	0.505	CbGbCtD
Vecuronium—ABCB1—Gemcitabine—urinary bladder cancer	0.112	0.145	CbGbCtD
Vecuronium—ABCB1—Cisplatin—urinary bladder cancer	0.0816	0.106	CbGbCtD
Vecuronium—ABCB1—Etoposide—urinary bladder cancer	0.0802	0.104	CbGbCtD
Vecuronium—ABCB1—Doxorubicin—urinary bladder cancer	0.0547	0.0708	CbGbCtD
Vecuronium—ABCB1—Methotrexate—urinary bladder cancer	0.053	0.0686	CbGbCtD
Vecuronium—Injection site reaction—Mitomycin—urinary bladder cancer	0.00868	0.04	CcSEcCtD
Vecuronium—Injection site pain—Thiotepa—urinary bladder cancer	0.00538	0.0248	CcSEcCtD
Vecuronium—Erythema—Mitomycin—urinary bladder cancer	0.00382	0.0176	CcSEcCtD
Vecuronium—Respiratory failure—Gemcitabine—urinary bladder cancer	0.00376	0.0173	CcSEcCtD
Vecuronium—Apnoea—Etoposide—urinary bladder cancer	0.00372	0.0171	CcSEcCtD
Vecuronium—Injection site reaction—Gemcitabine—urinary bladder cancer	0.00367	0.0169	CcSEcCtD
Vecuronium—Shock—Mitomycin—urinary bladder cancer	0.00306	0.0141	CcSEcCtD
Vecuronium—Rash—Valrubicin—urinary bladder cancer	0.00285	0.0131	CcSEcCtD
Vecuronium—Dermatitis—Valrubicin—urinary bladder cancer	0.00285	0.0131	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Gemcitabine—urinary bladder cancer	0.00277	0.0128	CcSEcCtD
Vecuronium—Paralysis—Methotrexate—urinary bladder cancer	0.00272	0.0125	CcSEcCtD
Vecuronium—Redness—Epirubicin—urinary bladder cancer	0.00262	0.0121	CcSEcCtD
Vecuronium—Face oedema—Gemcitabine—urinary bladder cancer	0.00259	0.0119	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Cisplatin—urinary bladder cancer	0.00258	0.0119	CcSEcCtD
Vecuronium—Paralysis—Epirubicin—urinary bladder cancer	0.00254	0.0117	CcSEcCtD
Vecuronium—Redness—Doxorubicin—urinary bladder cancer	0.00242	0.0112	CcSEcCtD
Vecuronium—CHRNA1—prostate gland—urinary bladder cancer	0.00242	0.216	CbGeAlD
Vecuronium—Face oedema—Cisplatin—urinary bladder cancer	0.00241	0.0111	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Etoposide—urinary bladder cancer	0.00237	0.0109	CcSEcCtD
Vecuronium—Paralysis—Doxorubicin—urinary bladder cancer	0.00235	0.0109	CcSEcCtD
Vecuronium—Muscular weakness—Fluorouracil—urinary bladder cancer	0.00232	0.0107	CcSEcCtD
Vecuronium—Rash erythematous—Epirubicin—urinary bladder cancer	0.00231	0.0106	CcSEcCtD
Vecuronium—Bronchospasm—Gemcitabine—urinary bladder cancer	0.00228	0.0105	CcSEcCtD
Vecuronium—Apnoea—Methotrexate—urinary bladder cancer	0.00223	0.0103	CcSEcCtD
Vecuronium—Connective tissue disorder—Thiotepa—urinary bladder cancer	0.00217	0.00999	CcSEcCtD
Vecuronium—Injection site pain—Epirubicin—urinary bladder cancer	0.00217	0.00998	CcSEcCtD
Vecuronium—Rash erythematous—Doxorubicin—urinary bladder cancer	0.00214	0.00985	CcSEcCtD
Vecuronium—Cardiac disorder—Thiotepa—urinary bladder cancer	0.00205	0.00943	CcSEcCtD
Vecuronium—CHRNA2—prostate gland—urinary bladder cancer	0.00201	0.179	CbGeAlD
Vecuronium—Injection site pain—Doxorubicin—urinary bladder cancer	0.002	0.00924	CcSEcCtD
Vecuronium—Angiopathy—Thiotepa—urinary bladder cancer	0.002	0.00922	CcSEcCtD
Vecuronium—Immune system disorder—Thiotepa—urinary bladder cancer	0.00199	0.00918	CcSEcCtD
Vecuronium—Mediastinal disorder—Thiotepa—urinary bladder cancer	0.00199	0.00916	CcSEcCtD
Vecuronium—Rash—Mitomycin—urinary bladder cancer	0.00196	0.00905	CcSEcCtD
Vecuronium—Dermatitis—Mitomycin—urinary bladder cancer	0.00196	0.00904	CcSEcCtD
Vecuronium—Bronchospasm—Etoposide—urinary bladder cancer	0.00195	0.00897	CcSEcCtD
Vecuronium—Respiratory failure—Methotrexate—urinary bladder cancer	0.00192	0.00887	CcSEcCtD
Vecuronium—Erythema—Thiotepa—urinary bladder cancer	0.00192	0.00885	CcSEcCtD
Vecuronium—CHRNB1—prostate gland—urinary bladder cancer	0.00187	0.167	CbGeAlD
Vecuronium—Connective tissue disorder—Gemcitabine—urinary bladder cancer	0.00182	0.0084	CcSEcCtD
Vecuronium—Injection site reaction—Epirubicin—urinary bladder cancer	0.00176	0.0081	CcSEcCtD
Vecuronium—Cardiac disorder—Gemcitabine—urinary bladder cancer	0.00172	0.00793	CcSEcCtD
Vecuronium—Connective tissue disorder—Cisplatin—urinary bladder cancer	0.0017	0.00783	CcSEcCtD
Vecuronium—Angiopathy—Gemcitabine—urinary bladder cancer	0.00168	0.00776	CcSEcCtD
Vecuronium—Immune system disorder—Gemcitabine—urinary bladder cancer	0.00168	0.00772	CcSEcCtD
Vecuronium—Mediastinal disorder—Gemcitabine—urinary bladder cancer	0.00167	0.0077	CcSEcCtD
Vecuronium—Injection site reaction—Doxorubicin—urinary bladder cancer	0.00163	0.0075	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—urinary bladder cancer	0.00162	0.00748	CcSEcCtD
Vecuronium—Erythema—Gemcitabine—urinary bladder cancer	0.00161	0.00744	CcSEcCtD
Vecuronium—Cardiac disorder—Cisplatin—urinary bladder cancer	0.0016	0.0074	CcSEcCtD
Vecuronium—Flushing—Cisplatin—urinary bladder cancer	0.0016	0.0074	CcSEcCtD
Vecuronium—Erythema—Fluorouracil—urinary bladder cancer	0.00159	0.00732	CcSEcCtD
Vecuronium—Immune system disorder—Cisplatin—urinary bladder cancer	0.00156	0.0072	CcSEcCtD
Vecuronium—Mediastinal disorder—Cisplatin—urinary bladder cancer	0.00156	0.00718	CcSEcCtD
Vecuronium—Nervous system disorder—Thiotepa—urinary bladder cancer	0.00154	0.00708	CcSEcCtD
Vecuronium—Tachycardia—Thiotepa—urinary bladder cancer	0.00153	0.00705	CcSEcCtD
Vecuronium—Skin disorder—Thiotepa—urinary bladder cancer	0.00152	0.00701	CcSEcCtD
Vecuronium—Erythema—Cisplatin—urinary bladder cancer	0.0015	0.00694	CcSEcCtD
Vecuronium—Flushing—Etoposide—urinary bladder cancer	0.00147	0.00678	CcSEcCtD
Vecuronium—Cardiac disorder—Etoposide—urinary bladder cancer	0.00147	0.00678	CcSEcCtD
Vecuronium—Angiopathy—Etoposide—urinary bladder cancer	0.00144	0.00662	CcSEcCtD
Vecuronium—Immune system disorder—Etoposide—urinary bladder cancer	0.00143	0.00659	CcSEcCtD
Vecuronium—Mediastinal disorder—Etoposide—urinary bladder cancer	0.00143	0.00658	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Methotrexate—urinary bladder cancer	0.00142	0.00653	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—urinary bladder cancer	0.00137	0.00629	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Epirubicin—urinary bladder cancer	0.00133	0.00611	CcSEcCtD
Vecuronium—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.00132	0.00607	CcSEcCtD
Vecuronium—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.0013	0.00597	CcSEcCtD
Vecuronium—Nervous system disorder—Gemcitabine—urinary bladder cancer	0.00129	0.00596	CcSEcCtD
Vecuronium—Skin disorder—Gemcitabine—urinary bladder cancer	0.00128	0.0059	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—urinary bladder cancer	0.00127	0.00587	CcSEcCtD
Vecuronium—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.00127	0.00586	CcSEcCtD
Vecuronium—Tachycardia—Fluorouracil—urinary bladder cancer	0.00126	0.00583	CcSEcCtD
Vecuronium—Urticaria—Thiotepa—urinary bladder cancer	0.00124	0.00574	CcSEcCtD
Vecuronium—Face oedema—Epirubicin—urinary bladder cancer	0.00124	0.00571	CcSEcCtD
Vecuronium—Hypotension—Gemcitabine—urinary bladder cancer	0.00123	0.00568	CcSEcCtD
Vecuronium—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.00123	0.00566	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Doxorubicin—urinary bladder cancer	0.00123	0.00565	CcSEcCtD
Vecuronium—Hypotension—Fluorouracil—urinary bladder cancer	0.00121	0.00558	CcSEcCtD
Vecuronium—Nervous system disorder—Cisplatin—urinary bladder cancer	0.0012	0.00555	CcSEcCtD
Vecuronium—Tachycardia—Cisplatin—urinary bladder cancer	0.0012	0.00553	CcSEcCtD
Vecuronium—Skin disorder—Cisplatin—urinary bladder cancer	0.00119	0.0055	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.00117	0.00537	CcSEcCtD
Vecuronium—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00115	0.00532	CcSEcCtD
Vecuronium—Hypotension—Cisplatin—urinary bladder cancer	0.00115	0.00529	CcSEcCtD
Vecuronium—Face oedema—Doxorubicin—urinary bladder cancer	0.00115	0.00528	CcSEcCtD
Vecuronium—Muscular weakness—Epirubicin—urinary bladder cancer	0.00113	0.00522	CcSEcCtD
Vecuronium—Anaphylactic shock—Etoposide—urinary bladder cancer	0.00113	0.00519	CcSEcCtD
Vecuronium—Tachycardia—Etoposide—urinary bladder cancer	0.0011	0.00506	CcSEcCtD
Vecuronium—Skin disorder—Etoposide—urinary bladder cancer	0.00109	0.00504	CcSEcCtD
Vecuronium—Hypotension—Etoposide—urinary bladder cancer	0.00105	0.00485	CcSEcCtD
Vecuronium—Muscular weakness—Doxorubicin—urinary bladder cancer	0.00105	0.00483	CcSEcCtD
Vecuronium—Urticaria—Fluorouracil—urinary bladder cancer	0.00103	0.00474	CcSEcCtD
Vecuronium—Rash—Thiotepa—urinary bladder cancer	0.000988	0.00455	CcSEcCtD
Vecuronium—Dermatitis—Thiotepa—urinary bladder cancer	0.000987	0.00455	CcSEcCtD
Vecuronium—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000955	0.0044	CcSEcCtD
Vecuronium—CHRNB1—vagina—urinary bladder cancer	0.000923	0.0823	CbGeAlD
Vecuronium—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000905	0.00417	CcSEcCtD
Vecuronium—Urticaria—Etoposide—urinary bladder cancer	0.000894	0.00412	CcSEcCtD
Vecuronium—Cardiac disorder—Methotrexate—urinary bladder cancer	0.00088	0.00406	CcSEcCtD
Vecuronium—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000872	0.00402	CcSEcCtD
Vecuronium—Angiopathy—Methotrexate—urinary bladder cancer	0.000861	0.00397	CcSEcCtD
Vecuronium—Immune system disorder—Methotrexate—urinary bladder cancer	0.000857	0.00395	CcSEcCtD
Vecuronium—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000855	0.00394	CcSEcCtD
Vecuronium—Rash—Gemcitabine—urinary bladder cancer	0.000831	0.00383	CcSEcCtD
Vecuronium—Dermatitis—Gemcitabine—urinary bladder cancer	0.00083	0.00383	CcSEcCtD
Vecuronium—Hypersensitivity—Etoposide—urinary bladder cancer	0.000829	0.00382	CcSEcCtD
Vecuronium—Erythema—Methotrexate—urinary bladder cancer	0.000826	0.00381	CcSEcCtD
Vecuronium—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000824	0.0038	CcSEcCtD
Vecuronium—Flushing—Epirubicin—urinary bladder cancer	0.000824	0.0038	CcSEcCtD
Vecuronium—Rash—Fluorouracil—urinary bladder cancer	0.000817	0.00377	CcSEcCtD
Vecuronium—Dermatitis—Fluorouracil—urinary bladder cancer	0.000816	0.00376	CcSEcCtD
Vecuronium—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000807	0.00372	CcSEcCtD
Vecuronium—Angiopathy—Epirubicin—urinary bladder cancer	0.000805	0.00371	CcSEcCtD
Vecuronium—SLC22A1—renal system—urinary bladder cancer	0.000803	0.0715	CbGeAlD
Vecuronium—Immune system disorder—Epirubicin—urinary bladder cancer	0.000802	0.0037	CcSEcCtD
Vecuronium—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.0008	0.00369	CcSEcCtD
Vecuronium—Rash—Cisplatin—urinary bladder cancer	0.000774	0.00357	CcSEcCtD
Vecuronium—Dermatitis—Cisplatin—urinary bladder cancer	0.000774	0.00357	CcSEcCtD
Vecuronium—Erythema—Epirubicin—urinary bladder cancer	0.000773	0.00356	CcSEcCtD
Vecuronium—Flushing—Doxorubicin—urinary bladder cancer	0.000762	0.00351	CcSEcCtD
Vecuronium—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000762	0.00351	CcSEcCtD
Vecuronium—Angiopathy—Doxorubicin—urinary bladder cancer	0.000745	0.00344	CcSEcCtD
Vecuronium—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000742	0.00342	CcSEcCtD
Vecuronium—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.00074	0.00341	CcSEcCtD
Vecuronium—Erythema—Doxorubicin—urinary bladder cancer	0.000715	0.0033	CcSEcCtD
Vecuronium—Rash—Etoposide—urinary bladder cancer	0.000709	0.00327	CcSEcCtD
Vecuronium—Dermatitis—Etoposide—urinary bladder cancer	0.000709	0.00327	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000698	0.00322	CcSEcCtD
Vecuronium—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000674	0.00311	CcSEcCtD
Vecuronium—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000661	0.00305	CcSEcCtD
Vecuronium—Skin disorder—Methotrexate—urinary bladder cancer	0.000655	0.00302	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000653	0.00301	CcSEcCtD
Vecuronium—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000631	0.00291	CcSEcCtD
Vecuronium—Hypotension—Methotrexate—urinary bladder cancer	0.00063	0.0029	CcSEcCtD
Vecuronium—Shock—Epirubicin—urinary bladder cancer	0.000621	0.00286	CcSEcCtD
Vecuronium—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000619	0.00285	CcSEcCtD
Vecuronium—Tachycardia—Epirubicin—urinary bladder cancer	0.000616	0.00284	CcSEcCtD
Vecuronium—Skin disorder—Epirubicin—urinary bladder cancer	0.000613	0.00282	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000605	0.00279	CcSEcCtD
Vecuronium—CHRNB1—lymph node—urinary bladder cancer	0.000597	0.0532	CbGeAlD
Vecuronium—Hypotension—Epirubicin—urinary bladder cancer	0.000589	0.00272	CcSEcCtD
Vecuronium—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000584	0.00269	CcSEcCtD
Vecuronium—SLC22A1—vagina—urinary bladder cancer	0.000581	0.0518	CbGeAlD
Vecuronium—Shock—Doxorubicin—urinary bladder cancer	0.000574	0.00265	CcSEcCtD
Vecuronium—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000572	0.00264	CcSEcCtD
Vecuronium—Tachycardia—Doxorubicin—urinary bladder cancer	0.00057	0.00263	CcSEcCtD
Vecuronium—Skin disorder—Doxorubicin—urinary bladder cancer	0.000567	0.00261	CcSEcCtD
Vecuronium—Hypotension—Doxorubicin—urinary bladder cancer	0.000545	0.00251	CcSEcCtD
Vecuronium—Urticaria—Methotrexate—urinary bladder cancer	0.000535	0.00247	CcSEcCtD
Vecuronium—Urticaria—Epirubicin—urinary bladder cancer	0.000501	0.00231	CcSEcCtD
Vecuronium—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000497	0.00229	CcSEcCtD
Vecuronium—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000465	0.00214	CcSEcCtD
Vecuronium—Urticaria—Doxorubicin—urinary bladder cancer	0.000464	0.00214	CcSEcCtD
Vecuronium—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.00043	0.00198	CcSEcCtD
Vecuronium—Rash—Methotrexate—urinary bladder cancer	0.000425	0.00196	CcSEcCtD
Vecuronium—Dermatitis—Methotrexate—urinary bladder cancer	0.000425	0.00196	CcSEcCtD
Vecuronium—Rash—Epirubicin—urinary bladder cancer	0.000398	0.00183	CcSEcCtD
Vecuronium—Dermatitis—Epirubicin—urinary bladder cancer	0.000397	0.00183	CcSEcCtD
Vecuronium—ABCB1—prostate gland—urinary bladder cancer	0.00038	0.0339	CbGeAlD
Vecuronium—Rash—Doxorubicin—urinary bladder cancer	0.000368	0.0017	CcSEcCtD
Vecuronium—Dermatitis—Doxorubicin—urinary bladder cancer	0.000368	0.00169	CcSEcCtD
Vecuronium—ABCB1—seminal vesicle—urinary bladder cancer	0.000321	0.0286	CbGeAlD
Vecuronium—ABCB1—epithelium—urinary bladder cancer	0.000279	0.0249	CbGeAlD
Vecuronium—ABCB1—renal system—urinary bladder cancer	0.000259	0.0231	CbGeAlD
Vecuronium—ABCB1—urethra—urinary bladder cancer	0.000254	0.0227	CbGeAlD
Vecuronium—ABCB1—female reproductive system—urinary bladder cancer	0.000207	0.0185	CbGeAlD
Vecuronium—ABCB1—vagina—urinary bladder cancer	0.000188	0.0167	CbGeAlD
Vecuronium—ABCB1—lymph node—urinary bladder cancer	0.000121	0.0108	CbGeAlD
